Showing results (31-40 of 143) with videos related to
Sort By:
Pageof 15
Current Pharmaceutical Design|March 4, 2010
Autoantibodies in autoimmune diseasesM Eggert, U K Zettl, G NeeckActa Neurologica Scandinavica|November 22, 2013
Spasticity in patients with multiple sclerosis--clinical characteristics, treatment and quality of lifeP Flachenecker, T Henze, U K ZettlJournal of Neurology|May 16, 2007
Complementary and alternative medicine and coping in neuroimmunological diseasesA Apel, B Greim, U K ZettlFortschritte Der Neurologie-Psychiatrie|April 6, 2006
[Stress and progression in multiple sclerosis]A Apel, T Klauer, U K ZettlActa Neurologica Scandinavica|June 11, 2016
Symptomatic treatment in multiple sclerosis-interim analysis of a nationwide registryS Skierlo, P S Rommer, U K ZettlNeurogastroenterology and Motility|May 10, 2018
The sphingosine analog fingolimod (FTY720) enhances tone and contractility of rat gastric fundus smooth muscleM Kraft, U K Zettl, T Noack, et al.Der Nervenarzt|August 17, 2011
[Fingolimod treatment for multiple sclerosis patients. Infectiological aspects and recommendations for vaccinations]A Winkelmann, M Löbermann, E C Reisinger, et al.Der Nervenarzt|October 20, 2009
[Vaccination and multiple sclerosis]M Löbermann, A Winkelmann, E C Reisinger, et al.Clinical and Experimental Immunology|September 5, 2013
Monoclonal antibodies in treatment of multiple sclerosisP S Rommer, A Dudesek, O Stüve, et al.Clinical and Experimental Immunology|October 19, 2013
Multiple sclerosis treatment and infectious issues: update 2013A Winkelmann, M Loebermann, E C Reisinger, et al.Pageof 15